GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their ...
Acosta Group reports GLP-1 users are driving healthier eating, new product demand and labeling challenges, reshaping food, ...
Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are ...
Fact checked by Nick Blackmer GLP-1 medications have exploded in popularity over the last couple of years. In fact, a recent ...
Eli Lilly's tirzepatide, marketed under the brand Zepbound for weight loss, is the leading therapy in this niche. But due to ...
The latest episode of the "Breast Cancer Briefing" podcast highlights the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium. Join Dr. Sara Nunnery, Director of ...
GLP-1 receptor agonists are everywhere and everybody is talking about them. Most of the orthopaedic discussions have been around when to stop them before surgery. That matters, but much more is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results